Natco Pharma Ltd approves Q2FY27 results and declares a second interim dividend of ₹1.25 per share
- Q2 consolidated revenue was ₹1,019.4 crore, up 28.3% sequentially and down 30.3% year on year.
- Net profit was ₹202.6 crore, down 1.9% sequentially and 60.9% year on year; EBITDA margin was 30.4%.
- Record date: November 19, 2026; dividend payment starts November 27, 2026. Consolidated results received an unmodified limited-review report.
